Alentis Therapeutics the Claudin1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of antiClaudin1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin1 and
More...